Mergers & Acquisitions
Mar 2024

Molecule to Market Podcast: M&A Roundtable and 2024 Predictions

Originally posted by Molecule to Market on March 8, 2024.

James West, Managing Director in Lincoln’s Healthcare Group, recently joined the Molecule to Market podcast’s roundtable episode where he shared an update on the life sciences sector.

Listen to the podcast.

Summary

Meet Professionals with Complementary Expertise in Healthcare

Shahab Fatheazam

Vice Chairman | Healthcare

Chicago

Barry Freeman

Managing Director

Chicago

Ujwal Goenka

Managing Director

Mumbai

Matthew Lee

Managing Director, Head of UK & Co-Head of Healthcare, Europe

London

Dirk-Oliver Löffler

Managing Director & Co-Head of Healthcare, Europe

Frankfurt

Gaurav Marathe

Managing Director & Head of India

Mumbai

Don Matz

Managing Director

New York

Roderick O’Neill

Managing Director & Global Head of Healthcare

New York

François Rispoli

Managing Director

Paris

Michael Siano

Managing Director

New York

Emily Wildes

Managing Director & Co-Head of Healthcare

Chicago

Chris Huh

Director

Chicago

View All Team Members

Related Perspectives

The Renaissance of Healthcare Logistics
Apr 2026
perspectives, articles
View More
Lincoln International Adds Don Matz as Managing Director, Establishing Pharmaceutical Services M&A Coverage
Apr 2026
general news
View More
Real Deals | European Sponsors Eye Indian Buyers for Healthcare Assets
Mar 2026
in the press
View More
2025 Global Results
Jan 2026
general news
View More
View All Perspectives

Recent Transactions in Healthcare

Omnicare, a portfolio company of Equistone, has agreed to complete an owner buyout

Lincoln International advised Omnicare, a portfolio company of Equistone, on its agreement to complete an owner buyout

Healthcare
NORD Holding has acquired Hallmarq Veterinary Imaging

Lincoln International advised NORD Holding on the acquisition of Hallmarq Veterinary Imaging

Healthcare
CirrusMD has been acquired by Quantum Health

Lincoln International has advised CirrusMD on its acquisition by Quantum Health

Healthcare
Altus Capital Partners has sold ChoiceSpine to Zavation, a portfolio company of Gemspring

Lincoln International advised Altus Capital Partners on the sale of ChoiceSpine to Zavation, a portfolio company of Gemspring

Healthcare
NuvemRx Acquires par8o from R1 RCM

Lincoln International advised Clayton, Dubilier & Rice and TowerBrook on the sale of par8o, a division of R1 RCM, to NuvemRX, a portfolio company of Parthenon Capital

Healthcare
Medisolve, a portfolio company of H.I.G. Capital, has obtained incremental financing lines to support M&A

Lincoln International advised Medisolve, a portfolio company of H.I.G. Capital, in obtaining incremental financing lines to support M&A

Healthcare
CareHub, a portfolio company of Quadrivio Group, has raised a capex facility from Clessidra Capital Credit and Green Arrow Capital

Lincoln International advised CareHub, a portfolio company of Quadrivio Group, on the raise of a capex facility from Clessidra Capital Credit and Green Arrow Capital

Healthcare
Livingbridge has sold Fresh Tandartsen to European Dental Group, a portfolio company of Nordic Capital

Lincoln International advised Livingbridge on the sale of Fresh Tandartsen to European Dental Group, a portfolio company of Nordic Capital

Healthcare
View All Transactions